SC
Suresh Chand Saini
About Suresh Chand Saini
Data last updated:
Suresh Chand Saini is a Director at Alkon Formulation Private Limited (since 2017), Director at Septy Pharmaceuticals Private Limited (since 2022) and Director at Saksham Parenteral Private Limited (since 2026), and holds 4 more current directorships. The companies operate in Pharma, Paper and Wood. The 2 current companies with reported revenue have a combined latest revenue of ₹9.39 Cr; the largest is Alkon Formulation Private Limited at ₹7.74 Cr (FY 2024). Earlier, Suresh Chand Saini was a Director at Almech India Private Limited (from 2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Jan 2017 | 2017 | ₹7.74 Cr (FY 2024) | Active | |
| Director | 07 Mar 2022 | 2006 | ₹1.66 Cr (FY 2024) | Active | |
| Director | 25 Aug 2026 | 2026 | Active | ||
| Director | 05 Nov 2024 | 2024 | Active | ||
| Director | 13 Mar 2024 | 2024 | Active | ||
| Managing Director | 18 Jul 2022 | 2022 | Active | ||
| Director | 12 Aug 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Dec 2016 | 2016 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Suresh Chand Saini
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anju Kumari | 07652598 | Alkon Formulation Private Limited , Septy Pharmaceuticals Private Limited and 4 more | Director |
| Malvir Singh | 02729433 | Saksham Parenteral Private Limited | Director |
| Rubi Rani | 11678610 | Saksham Parenteral Private Limited | Director |
| Vikas Tripathi | 07519376 | Sunlife Biosciences Limited , Innocosmetica Wellness Limited | Director |
| Bebi | 10547971 | Innocosmetica Wellness Limited | Director |
| Balbir Singh | 10066111 | Anjushree Lifescience Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suresh Chand Saini
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suresh Chand Saini
Suresh Chand Saini currently holds 7 directorships: Alkon Formulation Private Limited (Director, since 12 Jan 2017, revenue ₹7.74 Cr (FY 2024)); Septy Pharmaceuticals Private Limited (Director, since 07 Mar 2022, revenue ₹1.66 Cr (FY 2024)); Saksham Parenteral Private Limited (Director, since 25 Aug 2026); Sunlife Biosciences Limited (Director, since 05 Nov 2024); Innocosmetica Wellness Limited (Director, since 13 Mar 2024); and 2 more.
Suresh Chand Saini was first appointed on 16 Dec 2016 as Director at Almech India Private Limited. The most recent appointment on record is 25 Aug 2026 at Saksham Parenteral Private Limited.
The 2 current companies of Suresh Chand Saini that report revenue have a combined latest revenue of ₹9.39 Cr: Alkon Formulation Private Limited ₹7.74 Cr (FY 2024); Septy Pharmaceuticals Private Limited ₹1.66 Cr (FY 2024).
Suresh Chand Saini held 1 earlier board appointment: Almech India Private Limited (Director, from 16 Dec 2016).
The current boards of Suresh Chand Saini's companies include Anju Kumari (Alkon Formulation Private Limited), Malvir Singh (Saksham Parenteral Private Limited), Rubi Rani (Saksham Parenteral Private Limited), Vikas Tripathi (Sunlife Biosciences Limited), Bebi (Innocosmetica Wellness Limited), Balbir Singh (Anjushree Lifescience Private Limited).